Why the study?
Cardiometabolic multimorbidity is common, but its association with activity limitation remains unknown.
Does cardiometabolic multimorbidity increase the odds of activity limitation in Canadian adults aged 45 to 85?
Does cardiometabolic multimorbidity increase the odds of activity limitation in Canadian adults aged 45 to 85?
Cardiometabolic multimorbidity, particularly combinations involving stroke, is strongly associated with increased odds of activity limitation in a dose-response relationship among Canadian adults.
Supports functional assessment in multimorbid adults; leaves open longitudinal confirmation of causality and interventions.
Background: Cardiometabolic multimorbidity (CM) is the diagnosis of at least two of: diabetes, stroke, or heart disease. CM is a common pattern of multimorbidity, however, the association between CM and activity limitation remains unknown. The objectives of this study were to 1) estimate the prevalence of activity limitations among Canadians with CM; and 2) quantify the association between CM and activity limitations.Methods: Using data from the Canadian Longitudinal Study on Aging (CLSA), we estimated the prevalence of CM in Canadians aged 45 to 85 (n=51,022). Multinomial logistic regression was used to quantify the association between CM and activity limitation, evaluated using the Older American Resources and Services (OARS) scale.Results: The prevalence of people living with CM and reporting any activity limitation was 27.4%, with the greatest proportion (47.9%) observed in participants living with all three cardiometabolic conditions. The multinomial odds ratio (or relative risk ratio (RRR)) of activity limitation was greatest amongst participants with all three CM conditions (any limitation: RRR = 11.229, 95% CI = 5.803 to 21.726). Of the two disease combinations, those that included stroke had the greatest odds of activity limitation (stroke and diabetes: RRR = 6.546, 95% CI = 4.436 – 9.661; stroke and myocardial infarction: RRR = 7.029, 95% CI = 4.168 – 11.853). Conclusion: Activity limitation is common amongst Canadians living with CM, and those with CM have an increased odds of reporting activity limitation relative to those with no CM conditions. The odds increase in dose-response relationship as one accumulates more CM conditions.
No takes yet. Share an insight, caveat, or question.
Fishbook et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: